AIMS: To investigate the additive prognostic impact of both forearm endothelial dysfunction and left ventricular mass (LVM) for future cardiovascular events. METHODS AND RESULTS: We enrolled 324 Caucasian, never treated, hypertensive outpatients. Endothelial function, by intra-arterial infusion of acetylcholine (ACh), and echocardiographic LVM were investigated. Patients were divided into tertiles on the basis of their increase in ACh-stimulated forearm blood flow (FBF) and LVM indexed by body surface area (LVMI). Cardiovascular events assessed were: fatal and non-fatal myocardial infarction, fatal and non-fatal stroke, transient cerebral ischaemic attack, unstable angina, coronary revascularization procedures, and symptomatic aorto-iliac occlusive disease. During a mean follow-up of 45.2+/-23.6 months, there were 47 new cardiovascular events (3.8 events/100 patient-years). The event rate was 6.8, 2.8, and 1.6% in the tertiles of ACh-stimulated FBF (log-rank test, P=0.0009), and 1.4, 3.4, and 6.6% in the tertiles of LVMI (log-rank test, P=0.0002), respectively. Besides, a significant interaction was documented between FBF and LVMI. In fact, the cardiovascular risk increases up to 11.4% in patients with low FBF and high LVMI. CONCLUSION: For the first time, we demonstrate that the co-existence of LVH and endothelial dysfunction in hypertensive patients increases significantly the risk of subsequent cardiovascular events.
AIMS: To investigate the additive prognostic impact of both forearm endothelial dysfunction and left ventricular mass (LVM) for future cardiovascular events. METHODS AND RESULTS: We enrolled 324 Caucasian, never treated, hypertensive outpatients. Endothelial function, by intra-arterial infusion of acetylcholine (ACh), and echocardiographic LVM were investigated. Patients were divided into tertiles on the basis of their increase in ACh-stimulated forearm blood flow (FBF) and LVM indexed by body surface area (LVMI). Cardiovascular events assessed were: fatal and non-fatal myocardial infarction, fatal and non-fatal stroke, transient cerebral ischaemic attack, unstable angina, coronary revascularization procedures, and symptomatic aorto-iliac occlusive disease. During a mean follow-up of 45.2+/-23.6 months, there were 47 new cardiovascular events (3.8 events/100 patient-years). The event rate was 6.8, 2.8, and 1.6% in the tertiles of ACh-stimulated FBF (log-rank test, P=0.0009), and 1.4, 3.4, and 6.6% in the tertiles of LVMI (log-rank test, P=0.0002), respectively. Besides, a significant interaction was documented between FBF and LVMI. In fact, the cardiovascular risk increases up to 11.4% in patients with low FBF and high LVMI. CONCLUSION: For the first time, we demonstrate that the co-existence of LVH and endothelial dysfunction in hypertensivepatients increases significantly the risk of subsequent cardiovascular events.
Authors: Ali Ahmed; Inmaculada B Aban; Michael T Weaver; Wilbert S Aronow; Jerome L Fleg Journal: Eur J Heart Fail Date: 2005-11-28 Impact factor: 15.534
Authors: Otto Kamp; Marco Metra; Silvia Bugatti; Luca Bettari; Alessandra Dei Cas; Natalia Petrini; Livio Dei Cas Journal: Drugs Date: 2010 Impact factor: 9.546
Authors: Velia Cassano; Giovanni Tripepi; Maria Perticone; Sofia Miceli; Irene Scopacasa; Giuseppe Armentaro; Marta Greco; Raffaele Maio; Marta Letizia Hribal; Giorgio Sesti; Francesco Perticone; Angela Sciacqua Journal: Hypertens Res Date: 2021-09-01 Impact factor: 3.872
Authors: Angela Sciacqua; Antonio Cimellaro; Luana Mancuso; Sofia Miceli; Velia Cassano; Maria Perticone; Teresa V Fiorentino; Francesco Andreozzi; Elena Succurro; Giorgio Sesti; Francesco Perticone Journal: Nutrients Date: 2020-02-05 Impact factor: 5.717
Authors: Maria Perticone; Antonio Cimellaro; Raffaele Maio; Benedetto Caroleo; Angela Sciacqua; Giorgio Sesti; Francesco Perticone Journal: Int J Mol Sci Date: 2016-03-26 Impact factor: 5.923